These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4082924)

  • 1. A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease.
    Tabaton M; Schenone A; Romagnoli P; Mancardi GL
    Acta Neuropathol; 1985; 68(3):218-23. PubMed ID: 4082924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of neuronal location on antigenic properties of neurofibrillary tangles.
    Tabaton M; Perry G; Autilio-Gambetti L; Manetto V; Gambetti P
    Ann Neurol; 1988 Jun; 23(6):604-10. PubMed ID: 3408241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B
    Neurosci Lett; 1985 May; 56(1):51-5. PubMed ID: 4011048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease.
    Probst A; Langui D; Lautenschlager C; Ulrich J; Brion JP; Anderton BH
    Acta Neuropathol; 1988; 77(1):61-8. PubMed ID: 3149122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):193-200. PubMed ID: 2539435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective loss of nigral neurons in Alzheimer's disease: a morphometric study.
    Uchihara T; Kondo H; Kosaka K; Tsukagoshi H
    Acta Neuropathol; 1992; 83(3):271-6. PubMed ID: 1373022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E epsilon4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease.
    Camicioli R; Kaye J; Payami H; Ball MJ; Murdoch G
    Dement Geriatr Cogn Disord; 1999; 10(6):437-41. PubMed ID: 10559556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibrillary degeneration and neuronal loss in Alzheimer's disease.
    Bondareff W; Mountjoy CQ; Roth M; Hauser DL
    Neurobiol Aging; 1989; 10(6):709-15. PubMed ID: 2628782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropathology of aminergic nuclei in Alzheimer's disease.
    Zweig RM; Ross CA; Hedreen JC; Steele C; Cardillo JE; Whitehouse PJ; Folstein MF; Price DL
    Ann Neurol; 1988 Aug; 24(2):233-42. PubMed ID: 3178178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of the substantia nigra in Alzheimer's disease.
    Reyes MG; Faraldi F; Chandran R; Verano A; Levi AC
    Panminerva Med; 1996 Mar; 38(1):8-14. PubMed ID: 8766873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases.
    Zarow C; Lyness SA; Mortimer JA; Chui HC
    Arch Neurol; 2003 Mar; 60(3):337-41. PubMed ID: 12633144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mamillary bodies in Alzheimer's disease.
    Grossi D; Lopez OL; Martinez AJ
    Acta Neurol Scand; 1989 Jul; 80(1):41-5. PubMed ID: 2506728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No correlation between nigral degeneration and striatal plaques in Alzheimer's disease.
    Love S; Wilcock GK; Matthews SM
    Acta Neuropathol; 1996; 91(4):432-6. PubMed ID: 8928622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of parkinsonism in patients with pure Alzheimer's disease.
    Horvath J; Burkhard PR; Herrmann FR; Bouras C; Kövari E
    J Alzheimers Dis; 2014; 39(1):115-20. PubMed ID: 24121968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved detection of substantia nigra pathology in Alzheimer's disease.
    Schneider JA; Bienias JL; Gilley DW; Kvarnberg DE; Mufson EJ; Bennett DA
    J Histochem Cytochem; 2002 Jan; 50(1):99-106. PubMed ID: 11748299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
    Rinne JO; Rummukainen J; Paljärvi L; Säkö E; Mölsä P; Rinne UK
    Prog Clin Biol Res; 1989; 317():325-32. PubMed ID: 2602422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons.
    Yamamoto T; Hirano A
    Ann Neurol; 1985 Jun; 17(6):573-7. PubMed ID: 4026228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles.
    Galloway PG; Grundke-Iqbal I; Iqbal K; Perry G
    J Neuropathol Exp Neurol; 1988 Nov; 47(6):654-63. PubMed ID: 2459316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
    Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
    Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine neurons with Alzheimer's neurofibrillary changes and alteration of tyrosine hydroxylase. Immunohistochemical investigation of tyrosine hydroxylase.
    Nakashima S; Ikuta F
    Acta Neuropathol; 1985; 66(1):37-41. PubMed ID: 2859729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.